Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-24 @ 6:28 PM
NCT ID:
NCT00588068
Eligibility Criteria:
Inclusion Criteria:
* Neuroblastic tumors diagnosed in accordance with the International Neuroblastoma Staging System
OR
* Clinically suspected neuroblastic tumors.
PK DRAW INCLUSION CRITERIA (FOR PK DRAWS ONLY):
PK Draw Inclusion Criteria
* Patients who receive naxitamab as part of their standard of care
Exclusion Criteria:
* None
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00588068
Study Brief:
Protocol Section:
NCT00588068